Among the predicted DUBs for PKM2, ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) emerged as a candidate due to its reported tumor-suppressive activity49 and a high confidence score of 0.823 (Fig. 6a). This evidence concerns the gene PKM and neoplasm.